Abiopharma

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Hyperfine Begins Commercial Launch of Optive AI™Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

Belite Bio to Participate in the BTIG Virtual Biotechnology Conference

Nkarta to Participate in the H.C. Wainwright“HCW@Home” Series

Ambulatory Surgery Center Completes WATER IV Trial Proceduresfor Prostate Cancer with Aquablation®Therapy

GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA’s list of AI authorizations for 4th Year with 100

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025

Humacyte Announces First Symvess™ Sale to Military Treatment Facility